findmyKOL

Adolfo Kaplan, MD

Basic profile

The University of Texas Rio Grande Valley

ORCIDNone on fileNPI↗
✓ Full record
RegionWeslaco, TX · South CentralSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Adolfo Kaplan is a Respiratory physician affiliated with The University of Texas Rio Grande Valley. OpenAlex indexes 12 publications with 1,118 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
12publications

Distinct works indexed by OpenAlex.

1,118citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
22companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1604 E 8th St
Suite A
Weslaco, TX 785965587

Telephone

956-447-5557

Registry record last updated 12 Nov 2018.

View the NPPES registry record

Industry payments

22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    52.7%
    Corticosteroid27.7%
    Fluticasone Propionate34%Trelegy Ellipta34%Breo Ellipta15%Symbicort6%Breyna5%Budesonide-Formoterol Fumarate2%Breztri Aerosphere2%Arnuity Ellipta2%Dulera1%Fluticasone-Vilanterol1%
    Part D<11 patients
    beta2-Adrenergic Agonist10.3%
    Albuterol Sulfate Hfa91%Ventolin Hfa9%
    Part D≥223 patients

    + 6 more classes in this area

  • Cardiovascular

    12.7%
    Loop diuretic4.3%
    Furosemide72%Torsemide18%Bumetanide10%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)2.2%
    Losartan Potassium100%
    Part D≥47 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    12.2%
    Corticosteroid4.8%
    Prednisone100%
    Part D≥192 patients
    Proton pump inhibitor4.5%
    Omeprazole53%Esomeprazole Magnesium32%Pantoprazole Sodium14%
    Part D≥59 patients

    + 4 more classes in this area

Where care is delivered (Part B)12% facility · 88% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”